Advertisement

Oral Oncology pp 187-215 | Cite as

Radiotherapy Aspects of Malignant Diseases of the Oral Cavity

  • B. J. Cummings
Part of the Developments in Oncology book series (DION, volume 20)

Abstract

The oral cavity forms the most proximal portion of the alimentary tract and serves as part of the upper airway. It provides the portal of entry to the body for food and fluids and serves as the initial site of digestive function through the mechanisms of mastication and salivation. The structures within the mouth, including the palate, tongue, and buccal regions, are an integral part of the speech apparatus. The oral mucosa is a protective barrier and collects sensory information relating to touch, pain, temperature, and taste. Efforts to treat tumors arising in the oral cavity must be directed not only at preserving the life of the patient, but also at preserving these functions as completely as possible.

Keywords

Oral Cavity Neck Dissection Hyperbaric Oxygen Radiation Therapy Oncology Group Neck Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lederman M. Cancer of the oral cavity: Observations on classification and natural history. Int J Radiat Oncol Biol Phys (6): 1559–1565, 1980.PubMedGoogle Scholar
  2. 2.
    Gilbert H, Kagan AR. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol (6): 357–380, 1974.PubMedGoogle Scholar
  3. 3.
    Frazell EL. A review of the treatment of cancer of the mobile portion of the tongue. Cancer (28): 1178–1181, 1971.PubMedGoogle Scholar
  4. 4.
    Fletcher GH. Place of irradiation in the management of head and neck cancers. Semin Oncol (4): 375–385, 1977.PubMedGoogle Scholar
  5. 5.
    Fitzpatrick PJ, Tepperman BS. Carcinoma of the floor of the mouth. J. Can Assoc Radiol (33): 148–153, 1982.PubMedGoogle Scholar
  6. 6.
    Hintz B, Charyulu K, Chandler JR, Sudarsanam A, Garciga C. Randomized study of local control and survival following radical surgery or radiation therapy in oral and laryngeal carcinomas. J Surg Oncol (12): 61–74, 1979.PubMedGoogle Scholar
  7. 7.
    Ange DW, Lindberg RD, Guillamondegui OM. Management of squamous cell carcinoma of the oral tongue and floor of mouth after excisional biopsy. Radiology (116): 143–146, 1975.PubMedGoogle Scholar
  8. 8.
    Fu KK, Chan EK, Phillips TL, Ray JW. Time, dose and volume factors in interstitial radium implants of carcinoma of the oral tongue. Radiology (119): 209–213, 1976.PubMedGoogle Scholar
  9. 9.
    Chu A, Fletcher GH. Incidence and causes of failures to control by irradiation the primary lesions in squamous cell carcinomas of the anterior two-thirds of the tongue and floor of mouth. AJR (117): 502–508, 1973.Google Scholar
  10. 10.
    Lees AW. The treatment of carcinoma of the anterior two-thirds of the tongue by radiotherapy. Int J Radiat Oncol Biol Phys (1): 849–858, 1976.PubMedGoogle Scholar
  11. 11.
    Mendenhall WM, Million RR, Cassisi NJ. Elective neck irradiation in squamous-cell carcinoma of the head and neck. Head Neck Surg (3): 15–20, 1980.PubMedGoogle Scholar
  12. 12.
    Gilbert EH, Goffinet DR, Bagshaw MA. Carcinoma of the oral tongue and floor of mouth: Fifteen years’ experience with linear accelerator therapy. Cancer (35): 1517–1524, 1975.PubMedGoogle Scholar
  13. 13.
    Pierquin B, Chassagne D, Baillet F, Castro JR. The place of implantation in tongue and floor of mouth cancer. JAMA (215): 961–963, 1971.PubMedGoogle Scholar
  14. 14.
    Bedwinek JM, Shukovsky LJ, Fletcher GH, Daley TE. Osteonecrosis in patients treated with definitive radiotherapy for squamous cell carcinomas of the oral cavity and naso- and oropharynx. Radiology (119): 665–667, 1976.PubMedGoogle Scholar
  15. 15.
    Fayos JV. The role of radium implants in cancer of the oral cavity and oral pharynx. Int J Radiat Oncol Biol Phys (6): 423–429, 1980.PubMedGoogle Scholar
  16. 16.
    Fletcher GH. Textbook of Radiotherapy, 3rd ed. Philadelphia: Lea and Febiger, 1980.Google Scholar
  17. 17.
    Sahatchiev A, Moushmov M, Kirov S. Results of radical treatment of cancer of the anterior two-thirds of the tongue. Cancer (30): 703–707, 1972.PubMedGoogle Scholar
  18. 18.
    Richaud P, Tapley ND: Lateralized lesions of the oral cavity and oropharynx treated in part with the electron beam. Int J Radiat Oncol Biol Phys (5): 461–465, 1979.PubMedGoogle Scholar
  19. 19.
    Barker JL, Fletcher GH. Time, dose and tumor volume relationships in megavoltage irradiation of squamous cell carcinomas of the retromolar trigone and anterior tonsillar pillar. Int J Radiat Oncol Biol Phys (2): 407–414, 1977.PubMedGoogle Scholar
  20. 20.
    Chung CK, Rahman SM, Lim ML, Constable WC. Squamous cell carcinoma of the hard palate. Int J Radiat Oncol Biol Phys (5): 191–196, 1979.PubMedGoogle Scholar
  21. 21.
    Farr HW, Arthur K. Epidermoid carcinoma of the mouth and pharynx, 1960–1964. Elective radical neck dissection. Clin Bull (1): 130–135, 1971.Google Scholar
  22. 22.
    Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev (2): 177–191, 1975.PubMedGoogle Scholar
  23. 23.
    Ketcham AS, Hoye RC, Chretien PB, Brace KC. Irradiation twenty-four hours preopera-tively. Am J Surg (118): 691–697, 1969.PubMedGoogle Scholar
  24. 24.
    Lawrence WJr, Terz JJ, Rogers C, King RE, Wolf JS, King ER. Preoperative irradiation for head and neck cancer: A prospective study. Cancer (33): 318–323, 1974.PubMedGoogle Scholar
  25. 25.
    Kramer S. Comparison of preoperative and postoperative radiation therapy for patients with carcinoma of the head and neck—The RTOG Study. Presented at Am Soc Ther Radiol, 1980.Google Scholar
  26. 26.
    Hamberger AD, Fletcher GH, Guillamondegui OM, Byers RM. Advanced squamous cell carcinoma of the oral cavity and oropharynx treated with irradiation and surgery. Radiology (119): 433–438, 1976.PubMedGoogle Scholar
  27. 27.
    Marcus RB, Million RR, Cassisi NJ. Postoperative irradiation for squamous cell carcinomas of the head and neck: Analysis of time-dose factors related to control above the clavicles. Int J Radiat Oncol Biol Phys (5): 1943–1949, 1979.PubMedGoogle Scholar
  28. 28.
    Vikram B. Importance of the time interval between surgery and postoperative radiation therapy in the combined management of head and neck cancer. Int J Radiat Oncol Biol Phys (5): 1837–1840, 1979.PubMedGoogle Scholar
  29. 29.
    Looser KG, Shah JP, Strong EW. The significance of “positive” margins in surgically resected epidermoid carcinomas. Head Neck Surg (1): 107–111, 1978.PubMedGoogle Scholar
  30. 30.
    Fletcher GH, Evers WT. Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology (95): 185–188, 1970.PubMedGoogle Scholar
  31. 31.
    Kraus FT, Perez-Mesa C. Verrucous carcinoma. Cancer (19): 26–38, 1966.PubMedGoogle Scholar
  32. 32.
    Memula N, Ridenhour G, Doss LL. Radiotherapeutic management of oral cavity verrucous carcinoma. Proc. 22nd Annual Meeting Amer Soc Ther Radiol, Int J Radiat Oncol Biol Phys (6): 1404, 1980.Google Scholar
  33. 33.
    Burns HP, Van Nostrand AWP, Palmer JA. Verrucous carcinoma of the oral cavity: Management by radiotherapy and surgery. Can J Surg (23): 19–25, 1980.PubMedGoogle Scholar
  34. 34.
    Fayos JV. Carcinoma of the mandible. Result of radiation therapy. Acta Radiol (Ther) (12): 378–386, 1973.Google Scholar
  35. 35.
    Porter EH. The local prognosis after radical radiotherapy for squamous carcinoma of the alveolus or the floor of the mouth. Clin Radiol (22): 139–143, 1971.PubMedGoogle Scholar
  36. 36.
    Henk JM. Radiosensitivity of lymph node metastases. Proc R Soc Med (68): 85–86, 1975.PubMedGoogle Scholar
  37. 37.
    del Regato JA, Spjut HJ. Ackerman and del Regato’s Cancer Diagnosis, Treatment, and Prognosis, 5th Ed. St. Louis: C.V. Mosby, 1977.Google Scholar
  38. 38.
    Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer (29): 1446–1449, 1972.PubMedGoogle Scholar
  39. 39.
    Mendenhall WM, Million RR, Cassisi NJ. Elective neck irradiation in squamous cell carcinoma of the head and neck. Head Neck Surg (3): 15–20, 1980.PubMedGoogle Scholar
  40. 40.
    Beahrs OH, Barber KW Jr. The value of radical dissection of structures of the neck in the management of carcinoma of the lip, mouth, and larynx. Arch Surg (85): 49–56, 1962.PubMedGoogle Scholar
  41. 41.
    Lyall D, Shetlin CF. Cancer of the tongue. Ann Surg (135): 489–496, 1952.PubMedGoogle Scholar
  42. 42.
    Sako K, Pradier RN, Marchetta FC, Pickren JW. Fallibility of palpation in the diagnosis of metastases to cervical nodes. Surg Gynecol Obstet (118): 989–990, 1964,PubMedGoogle Scholar
  43. 43.
    Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity. Cancer (46): 386–390, 1980.PubMedGoogle Scholar
  44. 44.
    Pointon, RC. Personal communication.Google Scholar
  45. 45.
    Jesse RH, Barkley HT Jr, Lindberg RD, Fletcher GH. Cancer of the oral cavity. Is elective neck dissection beneficial? Am J Surg (120): 505–508, 1970.PubMedGoogle Scholar
  46. 46.
    Northrop M, Fletcher GH, Jesse RH, Lindberg RD. Evolution of neck disease in patients with primary squamous cell carcinoma of the oral tongue, floor of mouth, and palatine arch, and clinically positive neck nodes neither fixed nor bilateral. Cancer (29): 23–30, 1972.PubMedGoogle Scholar
  47. 47.
    Nahum AM, Bone RC, Davidson TM. The case for elective prophylactic neck dissection. Trans Am Acad Ophtholmol Otolaryngol (82): 603–612, 1976.Google Scholar
  48. 48.
    Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer (29): 1450–1454, 1972.PubMedGoogle Scholar
  49. 49.
    Bagshaw MA, Thompson RW. Elective irradiation of the neck in patients with primary carcinoma of the head and neck. JAMA (217): 456–458, 1971.PubMedGoogle Scholar
  50. 50.
    Million RR. Elective neck irradiation for TxNo squamous carcinoma of the oral tongue and floor of mouth. Cancer (34): 149–155, 1974.PubMedGoogle Scholar
  51. 51.
    Horiuchi J, Adachi T. Some considerations on radiation therapy of tongue cancer. Cancer (28): 335–339, 1971.PubMedGoogle Scholar
  52. 52.
    Goffinet DR, Gilbert EH, Weller SA, Bagshaw MA. Irradiation of clinically uninvolved cervical lymph nodes. Can J Otolaryngol (4): 927–933, 1975.PubMedGoogle Scholar
  53. 53.
    Toker C. Some observations on the distribution of metastatic squamous carcinoma within cervical lymph nodes. Ann Surg (157): 419–426, 1963.PubMedGoogle Scholar
  54. 54.
    Wizenberg MJ, Bloedorn FG, Weiner S, Gracia J. Treatment of lymph node metastases in head and neck cancer. A radiotherapeutic approach. Cancer (29): 1455–1462, 1972.Google Scholar
  55. 55.
    Hanks GE, Bagshaw MA, Kaplan HS. The management of cervical lymph node metastasis by megavoltage radiotherapy. AJR (105): 74–82, 1969.Google Scholar
  56. 56.
    Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer (40): 145–151, 1977.PubMedGoogle Scholar
  57. 57.
    Strong EW. Preoperative radiation and radical neck dissection. Surg Clin North Am (49): 271–276, 1969.PubMedGoogle Scholar
  58. 58.
    Schneider JJ, Fletcher GH, Barkley HT Jr. Control by irradiation alone of nonfixed clinically positive lymph nodes from squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx. AJR (123): 42–48, 1975.Google Scholar
  59. 59.
    Bataini JP, Brugere J, Ghossein NA, Bernier J, Jaulerry C, Brunin F. Radiotherapeutic control of subclinical and clinical neck disease in patients with cancers of supraglottic larynx and pharynx. Proc. International Head and Neck Oncology Research Conference, Rosslyn, Virginia, Sept. 8–10, 1980. Abstract 1.2.Google Scholar
  60. 60.
    Cachin Y, Sancho-Garnier H, Micheau C, Marandas P. Nodal metastasis from carcinomas of the oropharynx. Otolaryngol Clin North Am (12): 145–154, 1979.PubMedGoogle Scholar
  61. 61.
    Goodwin WJ Jr, Chandler JR. Indications for radical neck dissection following radiation therapy. Arch Otolaryngol (104): 367–370, 1978.PubMedGoogle Scholar
  62. 62.
    Barkley HT Jr, Fletcher GH, Jesse RH, Lindberg RD. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg (124): 462–467, 1972.PubMedGoogle Scholar
  63. 63.
    Garofalo JA, Erlandson E, Strong EW, Lesser M, Gerold F, Spiro R, Schwartz M, Good RA. Serum zinc, serum copper, and the Cu/Zn ratio in patients with epidermoid cancers of the head and neck. J Surg Oncol (15): 381–386, 1980.PubMedGoogle Scholar
  64. 64.
    Silverman NA, Alexander JC Jr, Chretien PB. CEA levels in head and neck cancer. Cancer (37): 2204–2211, 1976.PubMedGoogle Scholar
  65. 65.
    Osoba D, Kersey PA, Clark RM, Rosen IB. Prognostic value of skin testing with dinitro-chlorobenzene in patients with head and neck cancer. Can J Surg (23): 43–44, 1980.PubMedGoogle Scholar
  66. 66.
    Molinari R. Study for a possible monitoring of radiosensitivity of oral and oropharyngeal carcinoma using evaluation of potential proliferative activity (L.I.). Proc. International Head and Neck Oncology Research Conference, Rosslyn, Virginia, Sept. 1980. Abstract 4.4.Google Scholar
  67. 67.
    Suit H, Lindberg R, Fletcher GH. Prognostic significance of extent of tumor regression at completion of radiation therapy. Radiology (84): 1100–1107, 1965.PubMedGoogle Scholar
  68. 68.
    Fazekas JT, Green JP, Vaeth JM, Schroeder AF. Postirradiation induration as a prognosticator. A retrospective analysis of squamous-cell carcinomas of the oral cavity and oropharynx. Radiology (102): 409–412, 1972.PubMedGoogle Scholar
  69. 69.
    Barkley HT Jr, Fletcher GH. The significance of residual disease after external irradiation of squamous-cell carcinoma of the oropharynx. Radiology (124): 493–495, 1977.PubMedGoogle Scholar
  70. 70.
    Mantyla M, Kortekangas AE, Valavaara RA, Nordman EM. Tumor regression during radiation treatment as a guide to prognosis. Br J Radiol (52): 972–977, 1979.PubMedGoogle Scholar
  71. 71.
    Sobel S, Rubin P, Keller B, Poulter C. Tumor persistence as a predictor of outcome after radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys (1): 873–880, 1976.PubMedGoogle Scholar
  72. 72.
    Taylor SG. Head and neck cancer. In Cancer Chemotherapy 1979, Annual 3, Pinedo HM (ed). New York: Elsevier, 1981, pp. 263–278.Google Scholar
  73. 73.
    Fazekas JT, Sommer C, Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Int J Radiat Oncol Biol Phys (6): 533–541, 1980.PubMedGoogle Scholar
  74. 74.
    Fu KK, Silverberg IJ, Phillips TL, Friedman MA. Combined radiotherapy and multidrug chemotherapy for advanced head and neck cancer: Results of a Radiation Therapy Oncology Group Pilot Study. Cancer Treat Rep (63): 351–357, 1979.PubMedGoogle Scholar
  75. 75.
    Lo TCM, Wiley AL Jr, Ansfield FJ, Brandenburg JH, Davis HL Jr, Gollin FF, Johnson RO, Ramirez G, Vermund H. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. AJR (126): 229–235, 1976.PubMedGoogle Scholar
  76. 76.
    Elkind MM. Fundamental questions in the combined use of radiation and chemicals in the treatment of cancer. Int J Radiat Oncol Biol Phys (5): 1711–1720, 1979.PubMedGoogle Scholar
  77. 77.
    Combined Modalities. Chemotherapy/radiotherapy—Meeting summary. Int J Radiat Oncol Biol Phys (5): 1721–1723, 1979.Google Scholar
  78. 78.
    Goldsmith MA, Carter SK. The integration of chemotherapy into a combined modality approach to cancer therapy. V. Squamous cell cancer of the head and neck. Cancer Treat Rev (2): 137–158, 1975.PubMedGoogle Scholar
  79. 79.
    Fu KK. Normal tissue effects of combined radiotherapy and chemotherapy for head and neck cancer. Front Radiat Ther Oncol (13): 113–132, 1979.Google Scholar
  80. 80.
    Chassagne D, Richard JM, Le Floch O. Results of interstitial curietherapy in T3 and T4 floor of the mouth and tongue cancers after previous arterial infusion chemotherapy. Panminerva Med (18): 45–49, 1976.PubMedGoogle Scholar
  81. 81.
    Cachin Y, Jortay A, Sancho H, Eschwege F, Madelain M, Desaulty A, Gerard P. Preliminary results of a randomized EORTC study comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx. Eur J Cancer (13): 1389–1395, 1977.PubMedGoogle Scholar
  82. 82.
    Shanta V, Krishnamurthi S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiol (31): 617–620, 1980.PubMedGoogle Scholar
  83. 83.
    O’Connor AD, Clifford P, Dalley VM, Durden-Smith DJ, Edwards WG, Hollis BA. Advanced head and neck cancer treated by combined radiotherapy and VBM cytotoxic regimen—four-year results. Clin Otolaryngol (4): 329–337, 1979.PubMedGoogle Scholar
  84. 84.
    Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol (26): 638–648, 1953.PubMedGoogle Scholar
  85. 85.
    Rubin P, Hanley J, Keys HM, Marcial V, Brady L. Carbogen breathing during radiation therapy. Int J Radiat Oncol Biol Phys (5): 1963–1970, 1979.PubMedGoogle Scholar
  86. 86.
    Henk JM, Kunkler PB, Smith CW. Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial. Lancet (II): 101–103, 1977.Google Scholar
  87. 87.
    Medical Research Council Working Party. Radiotherapy and hyperbaric oxygen. Lancet (II): 881–884, 1978.Google Scholar
  88. 88.
    Dische S. Hyperbaric oxygen: The Medical Research Council trials and their clinical significance. Br J Radiol (51): 888–894, 1979.Google Scholar
  89. 89.
    Raju MR. Heavy Particle Radiotherapy. London: Academic Press, 1980.Google Scholar
  90. 90.
    Catterall M, Bewley DK. Fast Neutrons in The Treatment of Cancer. New York: Academic Press, 1979.Google Scholar
  91. 91.
    Griffin TW, Weisberger EC, Laramore GE, Tong D, Blasko JC. Complications of combined surgery and neutron radiation therapy in patients with advanced carcinoma of the head and neck. Radiology (132): 177–178, 1979.PubMedGoogle Scholar
  92. 92.
    L.W. Brady (ed). Radiation Sensitizers, Their Use in The Clinical Management of Cancer. Masson Publishing U.S.A., 1980.Google Scholar
  93. 93.
    Denekamp J, McNally NJ, Fowler JF, Joiner MC. Misonidazole in radiotherapy: Are many small fractions best? Br J Radiol (53): 981–990, 1980.PubMedGoogle Scholar
  94. 94.
    Fazekas JT, Goodman RL, McLean CJ. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer. An RTOG pilot study (78–02). Int J Radiat Oncol Biol Phys (7): 1703–1708, 1981.PubMedGoogle Scholar
  95. 95.
    Sealy R, Williams A, Levin W, Blair R, Flockhart I, Stratford M, Minchinton A, Cridland S. Progress in investigations in the use of misonidazole in head and neck cancer as a hypoxic cell Radiation sensitizer and in combination with hyperbaric oxygen or hyperthermia. In Radiation Sensitizers: Their Use in the Clinical Management of Cancer, Brady LW (ed). Masson Publishing U.S.A., 1980, pp. 361–365.Google Scholar
  96. 96.
    Bush RS, Jenkin RDT, Allt WEC, Beale FA, Bean H, Dembo AJ, Pringle JF. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer (37) (Suppl III): 302–306, 1978.Google Scholar
  97. 97.
    Siemann DW, Hill RP, Bush RS. Smoking: The influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to Radiation. Int J Radiat Oncol Biol Phys (4): 657–662, 1978.PubMedGoogle Scholar
  98. 98.
    Pierquin BM, Mueller WK, Baillet F. Low dose rate ir Radiation of advanced head and neck cancers: Present status. Int J Radiat Oncol Biol Phys (4): 565–572, 1978.PubMedGoogle Scholar
  99. 99.
    Shukovsky LJ, Fletcher GH, Montague ED, Withers HR. Experience with twice-a-day fractionation in clinical radiotherapy. AJR (126): 155–162, 1976.PubMedGoogle Scholar
  100. 100.
    Backström A, Jakobsson PA, Littbrand B, Wersall J. Fractionation scheme with low individual doses in irradiation of carcinoma of the mouth. Acta Radiol (Ther) (12): 401–406, 1973.Google Scholar
  101. 101.
    Peracchia G, Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiences. Int J Radiat Oncol Biol Phys (7): 99–104, 1981.PubMedGoogle Scholar
  102. 102.
    Au SC, Archambeau JO. Continuous external irradiation. Int J Radiat Oncol Biol Phys (5): 253–255, 1979.PubMedGoogle Scholar
  103. 103.
    Holsti LR. Clinical experience with split-course radiotherapy. A randomized clinical trial. Radiology (92): 591–596, 1969.PubMedGoogle Scholar
  104. 104.
    Abramson N, Scruggs RP, Cavanaugh PJ. Short-course radiation therapy in the treatment of head and neck tumors. Radiology (118): 175–178, 1976.PubMedGoogle Scholar
  105. 105.
    Pilepich MV, Munzenrider JE, Rene JB. Unorthodox fractionation in the treatment of head and neck tumors. Int J Radiat Oncol Biol Phys (5): 249–252, 1979.PubMedGoogle Scholar
  106. 106.
    Million RR, Zimmermann RC. Evaluation of University of Florida split-course technique for various head and neck squamous cell carcinomas. Cancer (35): 1533–1536, 1975.PubMedGoogle Scholar
  107. 107.
    Wang CC. Radiation therapy in the management of oral malignant disease. Otolaryngol Clin North Am (12): 73–80, 1979.PubMedGoogle Scholar
  108. 108.
    Harwood AR, Cummings BJ. Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys (8): 1121–1126, 1982.PubMedGoogle Scholar
  109. 109.
    Rubin P, Casarett GW. Clinical Radiation Pathology. Philadelphia: W.B. Saunders, 1968.Google Scholar
  110. 110.
    Beumer J III, Curtis T, Harrison RE. Radiation therapy of the oral cavity: Sequelae and management, Part 1. Head Neck Surg (1): 301–312, 1979.PubMedGoogle Scholar
  111. 111.
    Beumer J, Curtis T, Harrison RE. Radiation therapy of the oral cavity: Sequelae and management, Part 2. Head Neck Surg (1): 392–408, 1979.PubMedGoogle Scholar
  112. 112.
    Phillips TL. Rationale for initial clinical trials and future development of radioprotectors. Cancer Clin Trials (3): 165–173, 1980.PubMedGoogle Scholar
  113. 113.
    Starcke EN, Shannon IL. How critical is the interval between extractions and irradiation in patients with head and neck malignancy? Oral Surg (43): 333–337, 1977.PubMedGoogle Scholar
  114. 114.
    Daley TE, Drane JB. Management of Dental Problems in Irradiated Patients. Houston: University of Texas Press, 1972.Google Scholar
  115. 115.
    Carl W, Schaaf NG. Dental care for the cancer patient. J Surg Oncol (6): 293–310, 1974.PubMedGoogle Scholar
  116. 116.
    Murray CG, Herson J, Daly TE, Zimmerman S. Radiation necrosis of the mandible: A 10-year study. Part I. Factors influencing the onset of necrosis. Int J Radiat Oncol Biol Phys (6): 543–548, 1980.PubMedGoogle Scholar
  117. 117.
    Murray CG, Herson J, Daly TE, Zimmerman S. Radiation necrosis of the mandible: A 10-year study. Part II. Dental factors; onset, duration and management of necrosis. Int J Radiat Oncol Biol Phys (6): 549–553, 1980.PubMedGoogle Scholar
  118. 118.
    Murray CG, Daly TE, Zimmerman SO. The relationship between dental disease and radiation necrosis of the mandible. Oral Surg (49): 99–104, 1980.PubMedGoogle Scholar
  119. 119.
    Davis JC, Dunn JM, Gates GA, Heimbach RD. Hyperbaric oxygen: A new adjunct in the management of radiation necrosis. Arch Otolaryngol (105): 58–61, 1979.PubMedGoogle Scholar
  120. 120.
    Joseph DL, Shumrick DL. Risks of head and neck surgery in previously irradiated patients. Arch Otolaryngol (97): 381–384, 1973.PubMedGoogle Scholar
  121. 121.
    Donaldson SS. Nutritional consequences of radiotherapy. Cancer Res (37): 2407–2413, 1977.PubMedGoogle Scholar
  122. 122.
    Sobol SM, Conoyer JM, Zill R, Thawley SE, Ogura JH. Nutritional concepts in the management of the head and neck cancer patient. II. Management concepts. Laryngoscope (89): 962–979, 1979.PubMedGoogle Scholar
  123. 123.
    Wynder EL, Dodo H, Bloch DA, Gantt RC, Moore OS. Epidemiologic investigation of multiple primary cancer of the upper alimentary and respiratory tracts. I. A retrospective study. Cancer (24): 730–739, 1969.PubMedGoogle Scholar
  124. 124.
    Kogelnik HD, Fletcher GH, Jesse RH. Clinical course of patients with squamous cell carcinoma of the upper respiratory and digestive tracts with no evidence of disease 5 years after initial treatment. Radiology (115): 423–427, 1975.PubMedGoogle Scholar
  125. 125.
    Cummings BJ, Clark RM. Cancer of the oral cavity. J Otolaryngol (11): 359–364, 1982.PubMedGoogle Scholar
  126. 126.
    Decroix Y, Ghossein NA. Experience of the Curie Institute in treatment of cancer of the mobile tongue. II Management of the neck nodes. Cancer (47): 503–508, 1981.PubMedGoogle Scholar
  127. 127.
    Glick JH, Taylor SG. Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: A review. Int J Radiat Oncol Biol Phys (7): 229–242, 1981.PubMedGoogle Scholar
  128. 128.
    Duncan W, Arnott SJ, Orr JA, Kerr GR. The Edinburgh experience of fast neutron therapy. Int J Radiat Oncol Biol Phys (8): 2155–2157, 1982.PubMedGoogle Scholar
  129. 129.
    Griffin TW, Lawrence GE, Hussey DH, Hendrickson FR, Rodriguez-Antunez A. Fast neutron beam radiation therapy in the United States. Int J Radiat Oncol Biol Phys (8): 2165–2168, 1982.PubMedGoogle Scholar
  130. 130.
    Phillips TL, Wasserman TH, Stetz J, Brady LW. Clinical trials of hypoxic cell sensitizers. Int J Radiat Oncol Biol Phys (8): 327–334, 1982.PubMedGoogle Scholar
  131. 131.
    Cummings BJ, Thomas GM, Rauth AM, Sorrenti V, Black B, Bush RS. Neurotoxic radiosensitizers and head and neck cancer patients — how many will benefit? Int J Radiat Oncol Biol Phys (8): 343–345, 1982.PubMedGoogle Scholar
  132. 132.
    Kotalik JF. Multiple daily fractions in radiotherapy. Cancer Treat Rev (8): 127–146, 1981.PubMedGoogle Scholar
  133. 133.
    Withers HR, Peters LJ, Thames HD, Fletcher GH. Hyperfractionation. Int J Radiat Oncol Biol Phys (8): 1807–1809, 1982.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • B. J. Cummings

There are no affiliations available

Personalised recommendations